TERAWULF INC. quarterly report, Q1 FY2014

Full document

Business context and reporting period

Important filing-identity discrepancy: The supplied filing is IKONICS Corporation’s unaudited Form 10-Q for the quarter ended March 31, 2014, not a TeraWulf Inc. filing. The summary below reflects the filing text provided.

IKONICS reported five business segments: Domestic, Export, IKONICS Imaging, Digital Texturing (DTX), and Micro-Machining. Interim results are unaudited and may not indicate full-year results.

Financial performance and condition

  • Revenue: $4.465 million, up 11.0% from $4.022 million in Q1 2013.
  • Profit and margins: Gross profit was $1.759 million, with a 39.4% gross margin versus $1.464 million and 36.4%. Operating income was $315,000 versus an operating loss of $174,000. Net income was $205,000, or $0.10 per diluted share, versus a net loss of $88,000, or $0.04 per share.
  • Expenses: SG&A decreased to $1.301 million from $1.466 million; R&D decreased to $143,000 from $173,000.
  • Cash flow: Operating cash flow was $354,000, compared with cash used of $248,000 in Q1 2013. Cash increased by $439,000 to $2.143 million. Investing activities provided $72,000; capital expenditures were $124,000.
  • Liquidity and debt: Current assets were $8.817 million and current liabilities $1.386 million, implying working capital of about $7.431 million. Cash and short-term investments totaled $3.403 million. No line-of-credit borrowings were outstanding; the company reported no other debt in the supplied text. Its secured line provides up to $1.25 million and expires May 31, 2015, if not renewed.
  • Balance sheet: Total assets were $14.742 million, total liabilities $1.913 million, and stockholders’ equity $12.829 million at March 31, 2014.

Material changes versus the prior comparable period

  • IKONICS Imaging sales increased $718,000, mainly due to a large initial stocking order from new distributor JDS Industries. DTX sales rose 11.1%; Domestic sales were similar to the prior year.
  • Export sales fell 17.7%, mainly reflecting weaker Asia sales; Micro-Machining sales fell 22.1% following the loss of a large mask customer.
  • Management attributed the higher gross margin to favorable sales mix, while increased DTX and Micro-Machining production costs partly offset the benefit.
  • The prior-year quarter included a tax benefit related to 2012 tax-law changes; Q1 2014 instead recorded $112,000 of tax expense, an effective rate of 35.4%.

Outlook, risks, and unusual items

  • Management expected some Asia sales to rebound toward historic levels during the remaining nine months of 2014, attributing part of the Q1 shortfall to weather-related shipping delays.
  • Capital expenditures for 2014 were expected to be approximately $600,000, including elevator upgrades and additional Micro-Machining equipment; the company expected to fund these from operating cash flow.
  • Management described ongoing development in Micro-Machining and DTX, including aerospace feasibility work and expansion of Micro-Machining capacity. It cautioned that defense-budget sequestration and delays in commercial aircraft launches could adversely affect some sales.
  • Foreign sales were approximately 27% of Q1 revenue, down from 36%. Management considered foreign-exchange exposure not significant; no hedging strategy was in place.
  • Key exposures include customer collections, inventory valuation and obsolescence, uncertain demand in export markets, and estimates for self-funded medical claims. The medical-claims liability was $55,000. A $309,000 federal capital-loss carryover valuation allowance relates to a carryover expiring at the end of 2014.
  • The company reported no material change in previously disclosed risk factors, no legal proceedings, and no off-balance-sheet arrangements. Management concluded disclosure controls were effective and reported no material change in internal control over financial reporting.

Important facts for investors to verify

  1. Confirm the issuer and filing: the supplied 10-Q identifies IKONICS Corporation, not TeraWulf Inc.
  2. Assess whether the Imaging distributor’s initial stocking order translated into recurring sales.
  3. Monitor Export/Asia recovery and the effects of losing the Micro-Machining mask customer.
  4. Track DTX and Micro-Machining production costs, capacity investment, and progress toward commercial aerospace business.
  5. Review the 2014 capital-spending plan, liquidity, and renewal status of the $1.25 million credit line.